New York, NY, United States of America

Marcus Kelly

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):

Title: The Innovative Mind of Marcus Kelly: A Look at His Contributions to Cancer Research

Introduction

Marcus Kelly, a prominent inventor based in New York, NY, has made significant strides in the field of cancer research through his innovative inventions. With a remarkable portfolio of 19 patents, he has focused his efforts on developing advanced therapeutic strategies aimed at treating various forms of cancer.

Latest Patents

Among his notable contributions are two recent patents that stand out in cancer treatment methodologies. The first, titled "Tubulysins and protein-tubulysin conjugates," outlines compounds, compositions, and methods for addressing diseases and disorders associated with cancer. This patent emphasizes the use of tubulysins and protein drug conjugates, which have the potential to revolutionize therapeutic approaches for cancer patients.

The second patent, "Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging," presents radiolabeled antibodies that assist in immuno-PET imaging. This invention aids in the detection of PD-L1 proteins within patients or samples, offering enhanced diagnostic capabilities that are crucial for effective cancer management.

Career Highlights

Marcus currently works at Regeneron Pharmaceuticals, Inc., a company known for its cutting-edge biomedical research and drug development. His dedication to advancing cancer therapies marks him as a leader in his field, contributing significantly to the pharmaceutical landscape.

Collaborations

Throughout his career, Marcus has collaborated with various talented professionals, including his coworkers Gavin Thurston and Jessica Kirshner. These partnerships foster an environment of innovation and collaboration, facilitating breakthroughs that lead to new cancer treatments.

Conclusion

In summary, Marcus Kelly is a distinguished inventor whose work in cancer research has generated significant advancements in treatment methodologies. With an impressive number of patents and collaborative efforts with other experts, he continues to impact the medical field profoundly. His innovations, particularly in tubulysins and immuno-PET imaging, hold promise for future cancer therapies and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…